Boehringer Ingelheim receives East Bay Innovation Award

Boehringer Ingelheim Fremont Inc. received the East Bay Innovation Award in recognition for its contribution to the East Bay’s culture of innovation. Boehringer Ingelheim’s Fremont, California site is an arm of its biopharmaceutical division and provides the entire production technology chain from DNA to drug substance. The site delivers services both for Boehringer Ingelheim’s own products and for its contract manufacturing business, called Boehringer Ingelheim BioXcellence™. The facility is a strategic partner, offering tailor-made contract development and manufacturing services to the biopharmaceutical industry.

The East Bay Innovation Award is sponsored jointly by The East Bay Economic Development Alliance and the San Francisco Business Times, and celebrates the cutting-edge businesses that make the East Bay one of the preeminent regions of innovation in the U.S.

“We are very pleased to receive this award that recognizes our achievements in innovation and our contribution to the Bay Area. Our company vision is Value through Innovation and this award is an example of how we provide value, not only to our patients, but also to the East Bay,” said Michael Howaldt, Vice President, Biopharmaceuticals Operations USA and Fremont Site Head.